APA aipamena

Kumarasamy, N., Poongulali, S., Beulah, F. E., Akite, E. J., Ayuk, L. N., Bollaerts, A., . . . Van Der Meeren, O. (2018). Long-term safety and immunogenicity of the M72/AS01(E) candidate tuberculosis vaccine in HIV-positive and -negative Indian adults: Results from a phase II randomized controlled trial. Medicine (Baltimore).

Chicago Style aipamena

Kumarasamy, Nagalingeswaran, et al. "Long-term Safety and Immunogenicity of the M72/AS01(E) Candidate Tuberculosis Vaccine in HIV-positive and -negative Indian Adults: Results From a Phase II Randomized Controlled Trial." Medicine (Baltimore) 2018.

MLA aipamena

Kumarasamy, Nagalingeswaran, et al. "Long-term Safety and Immunogenicity of the M72/AS01(E) Candidate Tuberculosis Vaccine in HIV-positive and -negative Indian Adults: Results From a Phase II Randomized Controlled Trial." Medicine (Baltimore) 2018.